Research & Development

Our cGMP clinical and commercial scale cell manufacturing facility in Aguadilla, Puerto Rico gives Cytovia streamlined control over cGMP production in a facility that has been designed to meet global regulatory expectations and readiness for FDA, EMA, and global regulatory audits. By operating modular clean rooms and bioreactors, the cGMP facility will provide capacity to support clinical and commercial operations. The facility has been designed to allow multi-product manufacturing, enabling Cytovia to produce iPSC-derived NK & CAR-NK therapeutics for thousands of patients.